Corporate Governance Scrutiny: Pfizer's legal threats against former executives Ian Read and Frank D'Amelio for collaborating with activist investor Starboard Value have raised concerns about...
Strategic Shift: Sanofi's $16.4B deal to sell 50% stake in Opella consumer health unit to CD&R signals strategic focus on innovative medicines and vaccines. Industry Trend: Major pharma players like...
Strategic Pivot: Bausch + Lomb's exploration of a sale represents a strategic shift from its tumultuous spin-off process, aiming to streamline operations and unlock value. Market Positioning: With a...